E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/6/2005 in the Prospect News Biotech Daily.

Calypte extends credit facility, cuts rate

New York, Dec. 6 - Calypte Biomedical Corp. said it amended its credit facility with its largest stockholder, Marr Technologies, BV, to extend the maturity and lower the interest rate.

The facility now expires on April 3, 2006 instead of Dec. 31, 2005. In addition, the interest rate for promissory notes is now 7% instead of 9%.

Based in Pleasanton, Calif., Calypte develops and commercializes diagnostic testing products for sexually transmitted diseases.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.